Plexus Corp. (NASDAQ:PLXS - Get Free Report) CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $156.39, for a total value of $234,585.00. Following the completion of the transaction, the chief executive officer now owns 74,271 shares in the company, valued at approximately $11,615,241.69. The trade was a 1.98 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Plexus Trading Up 1.7 %
NASDAQ PLXS traded up $2.69 on Friday, reaching $157.91. The company had a trading volume of 124,182 shares, compared to its average volume of 106,691. The firm has a market cap of $4.28 billion, a price-to-earnings ratio of 39.38 and a beta of 0.90. Plexus Corp. has a fifty-two week low of $90.18 and a fifty-two week high of $170.07. The business has a 50 day moving average of $159.55 and a two-hundred day moving average of $135.42. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.51 and a quick ratio of 0.71.
Plexus (NASDAQ:PLXS - Get Free Report) last issued its quarterly earnings data on Wednesday, October 23rd. The technology company reported $1.85 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.55 by $0.30. Plexus had a return on equity of 9.51% and a net margin of 2.82%. The company had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.01 billion. During the same period last year, the company earned $1.44 earnings per share. The firm's revenue was up 2.6% compared to the same quarter last year. Analysts forecast that Plexus Corp. will post 6.14 EPS for the current year.
Analysts Set New Price Targets
Several brokerages have commented on PLXS. StockNews.com raised Plexus from a "hold" rating to a "buy" rating in a research note on Monday, November 18th. KeyCorp started coverage on shares of Plexus in a research note on Tuesday, October 22nd. They issued a "sector weight" rating for the company. Stifel Nicolaus boosted their target price on shares of Plexus from $136.00 to $150.00 and gave the stock a "hold" rating in a research note on Tuesday, December 10th. Benchmark increased their price target on Plexus from $150.00 to $165.00 and gave the company a "buy" rating in a research note on Monday, October 28th. Finally, Needham & Company LLC upped their target price on Plexus from $144.00 to $162.00 and gave the stock a "buy" rating in a report on Friday, October 25th. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $147.25.
Read Our Latest Report on Plexus
Hedge Funds Weigh In On Plexus
Several hedge funds and other institutional investors have recently bought and sold shares of PLXS. Quarry LP grew its stake in Plexus by 573.5% during the third quarter. Quarry LP now owns 229 shares of the technology company's stock worth $31,000 after purchasing an additional 195 shares during the period. Quest Partners LLC grew its position in shares of Plexus by 36,700.0% during the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company's stock worth $38,000 after buying an additional 367 shares during the period. Point72 DIFC Ltd bought a new stake in shares of Plexus in the 3rd quarter valued at $51,000. Point72 Asia Singapore Pte. Ltd. acquired a new stake in Plexus in the third quarter worth $55,000. Finally, Farther Finance Advisors LLC raised its holdings in shares of Plexus by 89.4% during the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company's stock valued at $63,000 after purchasing an additional 219 shares during the period. Institutional investors and hedge funds own 94.45% of the company's stock.
About Plexus
(
Get Free Report)
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Read More
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.